An evaluation is due to start on 6 September 2021 into screening babies for severe combined immunodeficiency (SCID) in England. This article describes some of the new resources for parents and professionals that have been developed for the evaluation and points you towards where you can find them.
As part of our special series on 50 years of newborn blood spot screening, we’re excited to share some insights into the programme's early days from Professor Anne Green and Professor Rodney Pollitt.
We're marking 50 years of screening for phenylketonuria (PKU) in newborn babies with a special series of blog posts. We start by looking back at how it all started.
Related content and links
The PHE Screening team
Public Health England (PHE) provides support and advice to the NHS-led national screening programmes. These programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions. PHE also hosts the UK National Screening Committee (UK NSC) secretariat and supports the work of the committee.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.
Comments and moderation
- NHS diabetic eye screening services and the National Diabetes Audit join forces to evaluate diabetes care 16 September 2021
- Report published marking 25 years of UK National Screening Committee 15 September 2021
- Valuable feedback from newborn blood spot failsafe solution (NBSFS) survey 14 September 2021